Eicosanoid synthesis (Homo sapiens)
From WikiPathways
Description
In biochemistry, eicosanoids are signaling molecules made by oxidation of twenty-carbon essential fatty acids, (EFAs). They exert complex control over many bodily systems, mainly in inflammation or immunity, and as messengers in the central nervous system. Source: Wikipedia.
This pathway has been updated with information from LIPID MAPS>Eicosanoids [1]. Metabolites and proteins from this pathway are orange coloured and have an rounded rectangle shape (where an rectangle shape indicates that the node only occures in the LIPIDM APS pathway). Reactions occurring in the LIPID MAPS pathways are coloured orange (where a dashed line indicates that the reaction only occures in the LIPID MAPS pathway).
Proteins on this pathway have targeted assays available via the CPTAC Assay PortalQuality Tags
Ontology Terms
Bibliography
- Funk CD; ''Prostaglandins and leukotrienes: advances in eicosanoid biology.''; Science, 2001 PubMed Europe PMC Scholia
- Schieber A, Frank RW, Ghisla S; ''Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase.''; Eur J Biochem, 1992 PubMed Europe PMC Scholia
- Suzuki-Yamamoto T, Nishizawa M, Fukui M, Okuda-Ashitaka E, Nakajima T, Ito S, Watanabe K; ''cDNA cloning, expression and characterization of human prostaglandin F synthase.''; FEBS Lett, 1999 PubMed Europe PMC Scholia
- Korff JM, Jarabak J; ''''; , PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
11-HETE | Metabolite | LMFA03060085 (LIPID MAPS) | |
12-HETE | Metabolite | CHEBI:19138 (ChEBI) | |
12-HPETE | Metabolite | 71030-35-8 (CAS) | |
15-Dehydro-prostaglandin I2 | Metabolite | LMFA03010205 (LIPID MAPS) | Changed 15-oxo-prostaglandin I2 to 15-Dehydro-prostaglandin I2, since the enzyme listed mentions dehydrogenase, and pubchem mentions 15-Dehydro-prostaglandin I2 is created from Prostaglandin I2. |
15-HETE | Metabolite | CHEBI:64017 (ChEBI) | |
15-HPETE | Metabolite | 70981-96-3 (CAS) | |
15-deoxy-PGD2 | Metabolite | LMFA03010051 (LIPID MAPS) | |
15-deoxy-PGJ2 | Metabolite | LMFA03010021 (LIPID MAPS) | |
5-HETE | Metabolite | 70608-72-9 (CAS) | |
5-HPETE | Metabolite | LMFA03060108 (LIPID MAPS) | |
ALOX12 | GeneProduct | 239 (Entrez Gene) | |
ALOX15 | GeneProduct | 246 (Entrez Gene) | |
ALOX15B | GeneProduct | 247 (Entrez Gene) | |
ALOX5 | GeneProduct | 240 (Entrez Gene) | |
ALOX5AP | GeneProduct | 241 (Entrez Gene) | |
Arachidonic acid | Metabolite | LMFA01030001 (LIPID MAPS) | |
DPEP1 | GeneProduct | 1800 (Entrez Gene) | |
GGT1 | GeneProduct | 2678 (Entrez Gene) | |
GP | Metabolite | CHEBI:37739 (ChEBI) | AKA glycerophospholipids |
GSH peroxidase | GeneProduct | 1.11.1.9 (Enzyme Nomenclature) | |
LTA4H | GeneProduct | 4048 (Entrez Gene) | |
LTC4S | GeneProduct | 4056 (Entrez Gene) | |
Leukotriene A4 | Metabolite | LMFA03020023 (LIPID MAPS) | |
Leukotriene B4 | Metabolite | LMFA03020001 (LIPID MAPS) | |
Leukotriene C4 | Metabolite | LMFA03020003 (LIPID MAPS) | |
Leukotriene D4 | Metabolite | LMFA03020006 (LIPID MAPS) | |
Leukotriene E4 | Metabolite | LMFA03020002 (LIPID MAPS) | |
PGD2 11-ketoreduc | GeneProduct | 1.1.1.188 (Enzyme Nomenclature) | |
PGD2 | Metabolite | LMFA03010004 (LIPID MAPS) | |
PGE2 9-ketoreduc | GeneProduct | 1.1.1.189 (Enzyme Nomenclature) | |
PGG2 | Metabolite | LMFA03010009 (LIPID MAPS) | |
PGJ2 | Metabolite | LMFA03010019 (LIPID MAPS) | |
PLA2G2A | GeneProduct | 5320 (Entrez Gene) | |
PLA2G6 | GeneProduct | 8398 (Entrez Gene) | |
PNPLA3 | GeneProduct | PNPLA3 (HGNC) | |
PNPLA8 | GeneProduct | 50640 (Entrez Gene) | |
PTGDS | GeneProduct | 5730 (Entrez Gene) | |
PTGES2 | GeneProduct | 80142 (Entrez Gene) | |
PTGES | GeneProduct | 9536 (Entrez Gene) | |
PTGIS | GeneProduct | 5740 (Entrez Gene) | |
PTGS1 | GeneProduct | 5742 (Entrez Gene) | |
PTGS2 | GeneProduct | 5743 (Entrez Gene) | |
Per- oxidase | GeneProduct | 1.11.1.7 (Enzyme Nomenclature) | |
Pla2g4a | Protein | 5321 (Entrez Gene) | |
Pla2g4b | Protein | 100137049 (Entrez Gene) | |
Pla2g5 | Protein | 5322 (Entrez Gene) | |
Pla2g6 | Protein | 8398 (Entrez Gene) | |
Prostaglandin D2 | Metabolite | LMFA03010004 (LIPID MAPS) | |
Prostaglandin E2 | Metabolite | LMFA03010003 (LIPID MAPS) | |
Prostaglandin F2a | Metabolite | LMFA03010002 (LIPID MAPS) | |
Prostaglandin H2 | Metabolite | LMFA03010010 (LIPID MAPS) | |
Prostaglandin I2 | Metabolite | LMFA03010087 (LIPID MAPS) | |
Ptgs1 | Protein | 5742 (Entrez Gene) | |
Ptgs2 | Protein | 5743 (Entrez Gene) | |
TBXAS1 | GeneProduct | 6916 (Entrez Gene) | |
Thromboxane A2 | Metabolite | LMFA03030001 (LIPID MAPS) | |
Thromboxane A3 | Metabolite | LMFA03030005 (LIPID MAPS) | |
Thromboxane B2 | Metabolite | LMFA03030002 (LIPID MAPS) | |
dehydrogenase | GeneProduct | 1.1.1.231 (Enzyme Nomenclature) |
Annotated Interactions
Source | Target | Type | Database reference | Comment |
---|---|---|---|---|
Leukotriene A4 | Leukotriene B4 | mim-conversion | 22325 (Rhea) | |
Leukotriene A4 | Leukotriene C4 | mim-conversion | 17619 (Rhea) | |
Leukotriene C4 | Leukotriene D4 | mim-conversion | 31564 (Rhea) | |
Leukotriene D4 | Leukotriene E4 | mim-conversion | 48617 (Rhea) | |
Prostaglandin H2 | Thromboxane A2 | mim-conversion | 17138 (Rhea) |